Biosimilars (otherwise termed follow-on-biologics, or FOBs for short) stand for the versions of biopharmaceuticals, which have the resembling but not identical parent molecule, and are created either by living organisms or from living micro-organisms by way of rDNA (recombinant DNA) or supervised gene expression technologies. The approval of Biosimilars occurs via strictly defined regulatory paths based on whether FOBs have shown comparability with their reference substance.
The worldwide Biosimilars Market is anticipated to surpass a EUR 14.9bn mark by end 2018. The major drivers encompass cost efficiency of biosimilars versus their high-priced analogues, the enlarging thirst for biotechnology drugs, imminent biotech drugs’ patent expiries, the planet’s aging population, and the rising frequency of critical illnesses. The illustrious actors on the global Biosimilars stage encompass Biocon, Intas Biopharmaceuticals, Cipla, Biopartners, Hospira, Wockhardt, Teva Pharmaceutical Industries, Sandoz International, amidst others.
The Catalogue’s research reports offer world, region and nation-wise analyses of the Biosimilars Market development over various time periods. The researches are lavish with discussions of the Biosimilars Industry growth rate, structure and capacity. The market trends, growth obstacles/stimulators, key products and those in R&D stage, and more issues are studied in the reports. Additionally, the research reports indicate and profile the leading players and hoped-for entrants, and offer market projections and forecasts.
Publications found:
174
Sort by:
Biosimilar Monoclonal Antibodies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Infliximab, Rituximab, Abciximab, Trastuzumab, Adalimumab, Bevacizumab, Others), By Application (Oncology, Chronic & Autoimmune Diseases, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Biosimilar Monoclonal Antibodies Market is projected to expand significantly, rising from USD 5.66 Billion in 2025 to USD 11.54 Billion by 2031, demonstrating a compound annual growth rate...
May 2026
185 pages
Biosimilar Testing and Development Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service Type (Analytical Testing, Clinical Testing), By Molecule Type (Monoclonal Antibodies, Recombinant Hormones, Insulin, Interferons, Enzymes, Others), By Therapeutic Area (Oncology, Autoimmune Diseases, Diabetes, Infectious Diseases, Neurology, Others), By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Biosimilar Testing and Development Services Market is poised for substantial growth, projected to increase from USD 3.73 Billion in 2025 to USD 7.53 Billion by 2031, demonstrating a robust...
May 2026
177 pages
US Biosimilars Market - 2024-2033
US$ 2,999.00
The US Biosimilars Market was valued at US$ 8.62 billion in 2024 and is anticipated to reach US$ 65.62 billion by 2033, at a CAGR of 0.255 from 2026 to 2032. The report delivers in-depth insights into...
April 2026
207 pages
Global Biosimilars Market Size Study and Forecast by Product Class (Monoclonal Antibodies, Recombinant Hormones (EPO, G-CSF), Insulins, Low-Molecular-Weight Heparins, Fusion Proteins & Others), by Indication (Oncology, Autoimmune & Chronic Inflammatory, Metabolic Disorders, Blood & Coagulation Disorders, Others), by End-user (Hospitals, Specialty Clinics, Retail & Mail-Order Pharmacies), by Manufacturing Type (In-house, Contract/Outsourced (CMO/CDMO)), by Expression System (Mammalian Cell (CHO, SP2/0), Microbial (E. coli, Yeast)), by Route of Administration (Intravenous, Sub-cutaneous), and Regional Forecasts 2026-2035
US$ 3,750.00
The biosimilars market comprises biologic products that are highly similar to approved reference biologics, offering equivalent therapeutic efficacy, safety, and quality while providing a cost advanta...
April 2026
285 pages
Europe Biosimilar Market Size, Share, Trends and Forecast by Molecule, Indication, Manufacturing Type, and Country, 2026-2034
US$ 3,999.00
The Europe biosimilar market size was valued at USD 16,233.5 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 62,878.9 Million by 2034, exhibiting a CAGR of 15.75% durin...
April 2026
145 pages
Global Biosimilars Market - 2024-2033
US$ 2,999.00
The Global Biosimilars Market was valued at US$ 30.30 Billion in 2024 and is anticipated to reach US$ 99.3 Billion by 2033, at a CAGR of 0.141 from 2026 to 2032. The report delivers in-depth insights...
February 2026
200 pages
Global Psoriasis Biosimilar Market Growth 2026-2032
US$ 3,660.00
The global Psoriasis Biosimilar market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. A psoriasis biosimilar refers...
January 2026
123 pages
Biosimilars Market Size, Share & Trends Analysis Report By Drug Class (Monoclonal Antibodies, Growth Factors & Hematopoietic Agents), By Indication (Autoimmune Disorders, Oncology, Diabetes Mellitus), By End Use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global biosimilars market size is expected to reach a value of USD 61.47 billion by 2025, according to a new report by ... Oncology accounted for the largest share in application segment in 2016 due to increasing adoption of low cost biosimilar drugs for cancer treatment Europe ...
January 2026
150 pages
The 2027-2032 World Outlook for Biosensors
US$ 1,195.00
This study covers the world outlook for biosensors across more than 190 countries. For each year reported, ... . This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product ...
January 2026
288 pages
The 2027-2032 World Outlook for Biosimilars
US$ 1,195.00
This study covers the world outlook for biosimilars across more than 190 countries. For each year reported, ... . This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product ...
January 2026
287 pages
The 2027-2032 World Outlook for Blood Pressure Transducers
US$ 1,195.00
... study covers the world outlook for blood pressure transducers across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for blood pressure transducers. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
The 2027-2032 World Outlook for Biosimilar Drugs
US$ 1,195.00
This study covers the world outlook for biosimilar drugs across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for biosimilar drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
288 pages
The 2027-2032 World Outlook for Biosimilar Monoclonal Antibodies (mAb)
US$ 1,195.00
This study covers the world outlook for biosimilar monoclonal antibodies (mAb) across more than 190 countries. For each year ... demand, or the P.I.E., for biosimilar monoclonal antibodies (mAb). It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also ...
January 2026
291 pages
The 2027-2032 World Outlook for Generic Biosimilars
US$ 1,195.00
This study covers the world outlook for generic biosimilars across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for generic biosimilars. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
Global Interferon Alpha-2a Biosimilar Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... display the global Interferon Alpha-2a Biosimilar market. Chapter 1, to describe Interferon Alpha-2a Biosimilar Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Interferon Alpha-2a Biosimilar, with ...
January 2026
99 pages
The 2027-2032 World Outlook for Biosensor Devices
US$ 1,195.00
This study covers the world outlook for biosensor devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Biosensors and Nanosensors
US$ 1,195.00
This study covers the world outlook for biosensors and nanosensors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
288 pages
Biosimilars and Biologics Market - 2024-2033
US$ 2,999.00
The Biosimilars and Biologics Market was valued at US$ 531.45 Billion in 2024 and is anticipated to reach US$ 1,773.77 Billion by 2033, at a CAGR of 0.144 from 2026 to 2032. The report delivers in-dep...
January 2026
207 pages
Pegfilgrastim Biosimilars Market 2026
US$ 2,999.00
The Pegfilgrastim Biosimilars Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including reg...
December 2025
243 pages
Biosimilars Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Oncology, Inflammatory and Autoimmune Diseases, Chronic Diseases, Blood Disorders, Growth Hormone Deficiency, Infectious Diseases, and Others), By Product (Monoclonal Antibodies, Insulin, Granulocyte Colony-Stimulating Factor, Erythropoietin, Recombinant Human Growth Hormone, Etanercept, Follitropin, Teriparatide, Interferons, Anticoagulants, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Biosimilars Market will grow from USD 31.07 Billion in 2024 to USD 42.36 Billion by 2030 at a 5.30% CAGR. Biosimilars are biological medical products highly similar to an already approved o...
December 2025
180 pages
Insulin biosimilars Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Rapid Acting biosimilars, Long Acting biosimilars, Premixed Acting biosimilars), By Disease Indication Type (Type I Diabetes, Type II Diabetes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End user (Hospitals, Ambulatory Surgical Centers, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Insulin biosimilars Market, valued at USD 1.55 Billion in 2024, is projected to experience a CAGR of 7.30% to reach USD 2.37 Billion by 2030. Insulin biosimilars are biological medicines hi...
November 2025
187 pages
Insulin Biosimilars Market 2026
US$ 2,999.00
The Insulin Biosimilars Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
207 pages
Oncology Biosimilars Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Drug Class (Monoclonal Antibodies, G-CSF, Hematopoietic Agents, Others), By Type of Cancer (Breast Cancer, Lung Cancer, Stomach Cancer, Prostate Cancer, Cervical Cancer, Blood Cancer, Brain Cancer, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Oncology Biosimilars Market, valued at USD 4.54 Billion in 2024, is projected to experience a CAGR of 6.94% to reach USD 6.79 Billion by 2030. Oncology biosimilars are biological products d...
November 2025
185 pages
Oncology Biosimilars Market - 2024-2033
US$ 2,999.00
The Oncology Biosimilars Market was valued at US$ 6.76 Billion in 2024 and is anticipated to reach US$ 30.83 Billion by 2033, at a CAGR of 0.186 from 2026 to 2032. The report delivers in-depth insight...
November 2025
210 pages
Adalimumab, Infliximab And Etanercept Biosimilars Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Adalimumab Biosimilars, Infliximab Biosimilars, Cipleumab), By Application (Crohn’s Disease, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Plaque Psoriasis, Other Applications), By Distribution Channel
US$ 3,950.00
The Adalimumab, Infliximab And Etanercept Biosimilars Market is valued at USD 6.4 billion in 2025 and is projected to grow at a CAGR of 16.7% to reach USD 25.6 billion by 2034.The adalimumab, inflixim...
October 2025
160 pages
Biologic & Biosimilar Ra Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Source (Microbial, Mammalian, Other Sources), By Disease (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, Other Diseases), By Manufacturing, By Mode Of Purchase, By Distribution Channel
US$ 3,950.00
The Biologic & Biosimilar Ra Drugs Market is valued at USD 12.1 billion in 2025 and is projected to grow at a CAGR of 5.5% to reach USD 19.5 billion by 2034.The market for biologic and biosimilar rheu...
October 2025
160 pages
Biosimilar Growth Hormones Market Outlook 2025-2034: Market Share, and Growth Analysis By Route Of Administration (Intravenous, Subcutaneous, Intramuscular, Oral), By Application (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Other Applications), By Distribution Channel
US$ 3,950.00
The Biosimilar Growth Hormones Market is valued at USD 1010.4 million in 2025 and is projected to grow at a CAGR of 8.7% to reach USD 2131.9 million by 2034.The Biosimilar Growth Hormones Market is ex...
October 2025
160 pages
Biosimilar Hormones Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Teriparatide Biosimilars, Follitropin Alfa Biosimilars, Insulin Biosimilars, Somatropin Biosimilars, Other Types), By Application (Research & Biotechnology, Diagnostics, Biocatalysts, Therapeutics, Other Applications), By Distribution Channel
US$ 3,950.00
The Biosimilar Hormones Market is valued at USD 7.9 billion in 2025 and is projected to grow at a CAGR of 22.8% to reach USD 50.3 billion by 2034.The Biosimilar Hormones Market is experiencing robust...
October 2025
160 pages
Biosimilar Interleukins Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (IL-17, IL-23, IL-1, IL-5, IL-6), By Application (Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease (IBD), Other Applications), By Distribution Channel
US$ 3,950.00
The Biosimilar Interleukins Market is valued at USD 9.3 billion in 2025 and is projected to grow at a CAGR of 34.7% to reach USD 135.9 billion by 2034.The Biosimilar Interleukins Market is emerging as...
October 2025
160 pages
Biosimilar Monoclonal Antibodies Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Synthetic Chemicals, Biopharmaceuticals, Other Types), By Compound (Infliximab, Rituximab, Abciximab, Trastuzumab, Adalimumab, Bevacizumab), By Application
US$ 3,950.00
The Biosimilar Monoclonal Antibodies Market is valued at USD 9.3 billion in 2025 and is projected to grow at a CAGR of 14% to reach USD 30.3 billion by 2034.The Biosimilar Monoclonal Antibodies Market...
October 2025
160 pages
Oral Biologics & Biosimilar Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn's Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others), By Molecule Type, By Distribution Channel
US$ 3,950.00
The Oral Biologics & Biosimilar Drugs Market is valued at USD 10.5 billion in 2025 and is projected to grow at a CAGR of 18.7% to reach USD 49.1 billion by 2034.The oral biologics and biosimilar drugs...
October 2025
160 pages
Oral Biologics & Biosimilars Market Outlook 2025-2034: Market Share, and Growth Analysis By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors, Immunostimulants, GPCR Modulators, Other Therapies), By Disease (Diabetes, Arthritis and Crohn’s Disease, Cancer, Infectious Disease, Other Autoimmune Disease, Other Diseases), By Molecule Type, By Distribution Channel
US$ 3,950.00
The Oral Biologics & Biosimilars Market is valued at USD 7.7 trillion in 2025 and is projected to grow at a CAGR of 16.2% to reach USD 29.8 trillion by 2034.The oral biologics and biosimilars market h...
October 2025
160 pages
Remicade Biosimilar Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (100mg/10ml, 500mg/50ml), By Disease Indication (Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Crohn’s Disease, Psoriatic Arthritis, Plaque Psoriasis), By Application
US$ 3,950.00
The Remicade Biosimilar Market is valued at USD 5.8 billion in 2025 and is projected to grow at a CAGR of 21.7% to reach USD 34 billion by 2034.The Remicade Biosimilar Market has gained substantial mo...
October 2025
160 pages
Trastuzumab Biosimilars Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Ogivri, Herzuma, Ontruzant, Trazimera, Other Products), By Indication (Adjuvant Breast Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer, Other Indications), By Distribution Channel
US$ 3,950.00
The Trastuzumab Biosimilars Market is valued at USD 8.1 billion in 2025 and is projected to grow at a CAGR of 24.1% to reach USD 56.6 billion by 2034.The Trastuzumab Biosimilars Market has emerged as...
October 2025
160 pages
Global Biosimilars Market Growth 2025-2031
US$ 3,660.00
The global Biosimilars market size is predicted to grow from US$ 9192 million in 2025 to US$ 25670 million in 2031; it is expected to grow at a CAGR of 18.7% from 2025 to 2031. The impact of the lates...
October 2025
155 pages
Global Oncology Biosimilars-Pipeline Insights - 2025 -2033
US$ 4,350.00
Oncology BiosimilarsIn recent years, cancer cases are increasing at a very rapid phase globally. The high cost of treatment of existing cancer therapeutics raises the interest in biosimilars.Nearly ev...
October 2025
180 pages
Biosimilar Contract Manufacturing Market Size, Share & Trends Analysis Report By Source (Mammalian, Non-mammalian), By Therapeutic Area (Oncology, Blood Disorders), By Service, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Biosimilar Contract Manufacturing Market The global biosimilar contract manufacturing market size was estimated at USD 7.84 billion in 2024 and is projected to reach USD 25.19 billion by 2033, growing...
September 2025
180 pages
